Creating extraordinary medicines™
Advancing a new class of ultra-tunable peptide therapeutics to unlock historically undruggable targets and achieve extraordinary outcomes for people affected by serious diseases.
Why extraordinary
“We aren’t pursuing incremental change. For us, ‘extraordinary’ means medicines that have the potential to have life-changing impact for patients and, by extension, the countless other individuals who care about them.”
Mathai Mammen, M.D., Ph.D. CEO, President and Chairman
We’ve custom-built every aspect of our research engine to adeptly deploy this powerful new modality and tackle problems previously considered impossible to solve.
Learn about our platformOur extraordinary medicines
Based on our ultra-tunable Helicon™ peptide platform, the novel medicines we’re advancing represent that rarest of opportunities: a chance to fundamentally change treatment possibilities for cancer and other diseases with critical need.
Explore our programs